Five names. New perspectives. Three positions.
The USCAP Nominating Committee and Board of Directors request Regular and Trainee Members to select future Academy leaders for a three-year term on the governing Board, April 1, 2021-March 31, 2024.
Please review the biographies of the candidates and vote for up to three by Wednesday, January 6, 2021.
Results will be announced at the Virtual Business Meeting on Saturday, March 13, 2021.
Meera A. Hameed, MD
Memorial Sloan Kettering Cancer Center/Weill Cornell Medical College
Dr. Hameed is Chief of Surgical Pathology at Memorial Sloan Kettering Cancer Center (MSKCC) and Professor of Pathology and Laboratory Medicine at Weill Cornell Medical College. After medical school (Madras University) and Pathology residency (Hahnemann University), she did oncologic surgical pathology fellowship training at Memorial Sloan Kettering Cancer Center in New York. Her career trajectory took her from Montefiore to Rutgers-NJMS, and ultimately to Memorial Sloan Kettering, where she became Chief of Surgical Pathology. She is also a molecular pathologist and served in leadership positions in this field at both Rutgers-NJMS and MSKCC (Program Director).
As Chief of Surgical Pathology, Dr. Hameed’s vision is to incorporate the use of digital technology into diagnostic pathology. She is actively involved in the digitization, integration of workflow and consultative access, and the use of digital platforms for interfacing with other disciplines. She is also Co-Director of the Warren Alpert Center for Digital and Computational Pathology, whose mission is to integrate digital pathology with both artificial intelligence and emerging new imaging technologies.
Dr. Hameed is internationally known for her expertise in bone and soft tissue pathology and has presented at many national and international conferences. She has served as a member of the Education Committee and Nominating Committees of the United States and Canadian Academy of Pathology (USCAP) and the Meritorious Award Committee of the American Society of Investigative Pathology. She is the Treasurer of the International Society of Bone and Soft Tissue Pathology. She is a member of the International Skeletal Society and has served as Executive Council Member of that society. She serves on the Molecular Oncology Committee of the College of American Pathologists and has served on the Clinical Practice Committee of the Association of Molecular Pathology. She has authored over 150 publications as well as many book chapters and review articles. She has served as short course Co-Director at USCAP. She serves as an Associate Editor of American Journal of Pathology and is an Editorial Board Member of Modern Pathology. In all these roles, she has focused on the continuing evolution of our discipline in the age of personalized medicine.
Jason L. Hornick, MD, PhD
Brigham and Women’s Hospital/Harvard Medical School
Dr. Jason Hornick received a BA from Amherst College (Amherst, MA) and an MD/PhD from the University of Southern California (Los Angeles, CA). He trained as a resident in Anatomic Pathology and pursued subspecialty fellowships in soft tissue pathology and gastrointestinal pathology at Brigham and Women’s Hospital (Boston, MA), where he is now the Director of Surgical Pathology and Immunohistochemistry. He is a Professor of Pathology at Harvard Medical School and a consultant at the Dana Farber Cancer Institute.
Dr. Hornick is Chair of the USCAP (United States and Canadian Academy of Pathology) Education Committee, past Chair of the USCAP Abstract Review Board and Assignment Committee, and past Chair of the Immunohistochemistry Committee for the CAP (College of American Pathologists). He was a member of the consensus and editorial working group for the 4th edition of the WHO (World Health Organization) Classification of Tumors of Soft Tissue and Bone and currently serves as an expert member of the editorial board for the 5th edition. Dr. Hornick has also contributed to the WHO Classifications of Tumors of the Digestive System, Skin Tumors, Tumors of the Urinary System and Male Genital Organs, and Tumors of the Breast. He was a member of the Soft Tissue Sarcoma Expert Panel for the AJCC (American Joint Committee on Cancer) and a member of the Sarcoma Analysis Working Group for The Cancer Genome Atlas (TCGA). He also serves on the Test Development and Advisory Committee for Anatomic Pathology for the American Board of Pathology.
Dr. Hornick serves on 12 editorial boards, including Modern Pathology and the American Journal of Surgical Pathology. He is a Regional Editor for Histopathology, an Associate Editor for Advances in Anatomic Pathology, the Consulting Editor for Surgical Pathology Clinics, and on the Executive Advisory Board of Archives of Pathology and Laboratory Medicine. Dr. Hornick is the Associate Editor for the American Registry of Pathology (formerly AFIP) Atlases. Dr. Hornick has published around 400 original papers, review articles, and book chapters and edited the textbook Practical Soft Tissue Pathology: A Diagnostic Approach, the 2nd edition of which was recently published. He is an Associate Editor for Sternberg’s Diagnostic Surgical Pathology.
Dr. Hornick received the 2012 Arthur Purdy Stout Society of Surgical Pathologists Annual Prize and the 2014 Jack Yardley Investigator Award from the Gastrointestinal Pathology Society. He teaches courses on the diagnosis of soft tissue tumors, gastrointestinal pathology, and diagnostic immunohistochemistry
Teri A. Longacre, MD
Dr. Longacre received a BA from St. John’s College, a BS from the University of New Mexico, and an MD from the University of New Mexico. She trained as a resident in Anatomic and Clinical Pathology at the University of New Mexico and pursued subspecialty fellowships in hematopathology, gastrointestinal pathology and general surgical pathology at Stanford Medicine, where she is now Director of Gynecologic Pathology and Gastrointestinal Pathology. She is the Richard L. Kempson Endowed Professor of Surgical Pathology at Stanford and directs the Gynecologic Pathology and Gastrointestinal Pathology Fellowship programs.
Dr. Longacre was a member of the 2013 and 2019 consensus and editorial working group for the WHO Classification of Tumors of the Female Genital Tract. She is a former President of the Association of Directors of Anatomic and Surgical Pathology and served on the Test Development and Advisory Committee for Anatomic Pathology for the American Board of Pathology for over 10 years.
Dr. Longacre has established a clinical research program that is focused on gynecologic and gastrointestinal pathology with an emphasis on diagnosis and screening of hereditary gynecologic and gastrointestinal cancer syndromes. She has published extensively in national and international journals and has authored or co-authored more than 200 peer reviewed manuscripts and book chapters in gynecologic and gastrointestinal pathology. She co-authored a textbook on the Uterine Corpus and Cervix. She serves on many editorial boards, including the American Journal of Surgical Pathology, and International Journal of Gynecologic Pathology. She is the Editor for Sternberg’s Diagnostic Surgical Pathology. She has extensive national and international teaching experience in gynecologic and gastrointestinal pathology and currently coordinates the Annual Dr. Richard L. Kempson Diagnostic Pathology Course for Scientific Symposiums International. She and her husband, a private practice pathologist, have three grown children and three grandchildren, who never fail to surprise and fascinate.
Rish K. Pai, MD, PhD
Mayo Clinic Arizona
Dr. Rish Pai received his BA from Pomona College in Claremont, CA and earned his MD, PhD from Case Western University School of Medicine in Cleveland, OH. He completed his anatomic pathology residency at the University of Chicago Medical Center, followed by a gastrointestinal and hepatic pathology fellowship at the same institution. Dr. Pai is currently Professor of Laboratory Medicine & Pathology and serves as a Consultant Pathologist at the Mayo Clinic in Phoenix, Arizona. Dr. Pai has lectured nationally and internationally on many aspects of gastrointestinal and hepatic pathology and has directed multiple GI CME courses including multiple USCAP short courses. He is currently President of the Rodger C. Haggitt Gastrointestinal Pathology Society, member of the USCAP Nominating Committee, and a former member of the USCAP Education Committee. Dr. Pai is a regular reviewer for numerous pathology and gastroenterology journals and serves on the Editorial Board of the American Journal of Surgical Pathology. He has published over 110 articles and written multiple book chapters in the fields of gastrointestinal and hepatic pathology.
Ming Zhou, MD, PhD
Tufts Medical Center/Tufts University School of Medicine
Dr. Ming Zhou is the Pathologist-in-Chief and Chair of the Tufts Medical Center Department of Pathology, and the Chair of the Department of Anatomic and Clinical Pathology, Tufts University School of Medicine in Boston, MA. He graduated summa cum laude from Fudan University Medical School in Shanghai, China. He completed his pathology residency training at the University of Michigan and a fellowship in the Urological and Kidney Diseases at the Johns Hopkins Hospital. He previously held faculty positions at Cleveland Clinic and New York University, and was the Dr. Charles T. Ashworth Endowed Professor of Pathology and the Director of Anatomic Pathology in the Department of Pathology, the University of Texas Southwestern Medical Center in Dallas.
Dr. Zhou has devoted his clinical and research effort to diagnostic urological pathology, and discovery and validation of tumor markers for urological malignancy. He has authored over 200 peer-reviewed articles and numerous book chapters, and he is the editor of 5 textbooks of urological and prostate pathology. He frequently lectures at national and international meetings on urological pathology. He was the co-course director of the prostate cancer long course at the 2018 USCAP Annual Meeting. He was a faculty of three USCAP short courses and four IM courses. He is currently the IM GU course coordinator. He served on the Cancer Committee of the College of American Pathologists from 2011 to 2017 and is one of the primary authors of the genitourinary cancer protocols, the guidelines for practicing pathologists on diagnosis and reporting genitourinary cancers. He also serves on the editorial board of several pathology journals, including the International Advisory Board of the Pathology International.